Founded in 1984, Amphion Innovations is a venture capital firm based in New York, New York, with additional offices in London, United Kingdom. They focus on investing in early-stage companies in the medical and technology sectors, particularly those with defensible intellectual property and growth potential in large markets. Their investments typically range from $5 million in the first one to two years, with additional capital requirements of up to $25 million. Amphion Innovations acts as a lead investor, aiming to acquire a significant ownership stake and influence in its portfolio companies. They invest in the form of preferred stock, convertible debt, or through stock warrants and options. The firm may reduce its shareholdings through the introduction of additional investors or through the sale or distribution of shares. They do not invest in speculative technologies requiring long development timeframes or excessive capital investment.